{"id":"W3010351291","doi":"10.1111/dom.14020","title":"Efficacy and safety of once‐monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo‐controlled, 16‐week randomized dose‐finding study","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sanofi (Canada)","funders":"Sanofi","keywords":"Placebo; Medicine; Type 2 diabetes; Adverse effect; Clinical endpoint; Metformin; Internal medicine; Randomized controlled trial; Diabetes mellitus; Randomization; Gastroenterology; Endocrinology; Insulin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003569644,0.001508587,0.003989763,0.0004556987,0.0004594537,0.0009961022,0.0008798175,0.002530819,0.004029312],"category_scores_gemma":[0.003169834,0.0009418533,0.002007907,0.0004069346,0.001016107,0.001601795,0.0004011327,0.002825879,0.0006813811],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005989659,"about_ca_system_score_gemma":0.0009023891,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000331661,"about_ca_topic_score_gemma":0.000666519,"domain_scores_codex":[0.9986154,0.0007959036,0.0001302016,0.0002110078,0.0001247625,0.0001226613],"domain_scores_gemma":[0.9979296,0.0006497385,0.000570478,0.0002153011,0.0001650232,0.000470013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9446136,0.0212214,0.001029105,0.0005169833,0.000789832,0.00004654565,0.00006716452,0.0002689486,0.006210625,0.00002449565,0.0003423332,0.02486902],"study_design_scores_gemma":[0.86279,0.1328992,0.002824372,0.00001937906,0.0003151341,0.00003604496,0.00001502083,0.0002209385,0.0005837636,0.00003284912,0.0002481634,0.0000151233],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925905,0.003362022,0.0005772362,0.0003807852,0.0001945378,0.001788213,0.0004386783,0.00007543455,0.0005925369],"genre_scores_gemma":[0.9888268,0.002104968,0.002298859,0.0009020355,0.000448589,0.003252723,0.0007656316,0.00003045212,0.001369948],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004029312,"threshold_uncertainty_score":0.01887834,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01223186821749371,"score_gpt":0.2430493415871766,"score_spread":0.2308174733696829,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}